Non-alcoholic Fatty Liver Diseases (NAFLD) News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

You may not have heard of fatty liver disease. Experts say you need to know
Non-alcoholic fatty liver disease happens when fat builds up in the liver. Experts say it’s hard to say what exactly causes it, but it’s associated with poor diet and not enough exercise. (Source: CBC | Health)
Source: CBC | Health - April 22, 2023 Category: Consumer Health News Tags: Radio/White Coat, Black Art Source Type: news

Light-to-moderate Alcohol Consumption and Progressive NAFLD Light-to-moderate Alcohol Consumption and Progressive NAFLD
This systemic review aimed to determine the impact of light-to-moderate alcohol use on the progression of NAFLD to NASH, fibrosis, cirrhosis and hepatocellular carcinoma.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 20, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Why Are NAFLD Treatments Failing in Clinical Trials? Why Are NAFLD Treatments Failing in Clinical Trials?
Dr Vlad Ratziu, professor of hepatology at the Sorbonne Universit é, shares his thoughts on why treatments for fatty liver disease continue to fall short, in a conversation with Dr Nancy Reau.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - April 17, 2023 Category: Gastroenterology Tags: Gastroenterology Expert Interview Source Type: news

Roche ’s Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study
Discussions with health authorities are ongoing and follow-up will continue for the final RFS data and more mature OS data at the next planned analysis.The IMbrave050 study is part of Roche ’s overall commitment to drive fundamental treatment change and improve outcomes for people living with liver cancer. Tecentriq plus Avastin was the first treatment in over a decade to significantly improve OS over the existing standard of care, based on data from the IMbrave150 study.3 The Tecentriq combination quickly became a standard of care in unresectable HCC and is clearly defined as a preferred front-line treatment in multiple...
Source: Roche Media News - April 16, 2023 Category: Pharmaceuticals Source Type: news

Roche ’s Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study
Discussions with health authorities are ongoing and follow-up will continue for the final RFS data and more mature OS data at the next planned analysis.The IMbrave050 study is part of Roche ’s overall commitment to drive fundamental treatment change and improve outcomes for people living with liver cancer. Tecentriq plus Avastin was the first treatment in over a decade to significantly improve OS over the existing standard of care, based on data from the IMbrave150 study.3 The Tecentriq combination quickly became a standard of care in unresectable HCC and is clearly defined as a preferred front-line treatment in multiple...
Source: Roche Investor Update - April 16, 2023 Category: Pharmaceuticals Source Type: news

PNPLA3 Genotype, Diabetes Predict Cirrhosis in NAFLD PNPLA3 Genotype, Diabetes Predict Cirrhosis in NAFLD
Those with diabetes and indeterminate FIB4 scores may have the same risk of cirrhosis as patients with a high FIB4.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 4, 2023 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Prediction of Advanced Liver Fibrosis in CHB Patients With NAFLD Prediction of Advanced Liver Fibrosis in CHB Patients With NAFLD
The authors developed a novel, non-invasive model for assessing advanced liver fibrosis in patients with chronic hepatitis B. Does it perform better than existing models?Journal of Viral Hepatitis (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 31, 2023 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

Vigorous Exercise Protects Against All-Cause Deaths in NAFLD Vigorous Exercise Protects Against All-Cause Deaths in NAFLD
Adults with NAFLD who regularly engage in vigorous physical activity may realize reductions in all-cause mortality.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

MAFLD Identifies Subjects With CVD Risk Better Than NAFLD MAFLD Identifies Subjects With CVD Risk Better Than NAFLD
A new study found that MAFLD was associated with a higher probability of cardiovascular disease than NAFLD. These findings could help better identify and address CVD risk in these individuals.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 30, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

No Added Benefit of Time-Restricted Eating in NAFLD No Added Benefit of Time-Restricted Eating in NAFLD
Adding time-restricted eating to calorie restriction does not provide added benefits in adults with obesity and nonalcoholic fatty liver disease.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 28, 2023 Category: Endocrinology Tags: Gastroenterology News Source Type: news

COVID-19 and Non-Alcoholic Fatty Liver Disease COVID-19 and Non-Alcoholic Fatty Liver Disease
A better understanding of the complex biological processes between COVID-19 and NAFLD could lead to better treatment and decision-making strategies.Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 23, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Digital Lifestyle Intervention Tools May Help in NAFLD Digital Lifestyle Intervention Tools May Help in NAFLD
Product development should factor in the unique, complex needs of patients with NAFLD, the authors say.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 20, 2023 Category: Endocrinology Tags: Gastroenterology News Source Type: news

Time-Restricted Eating No Better Than Cutting Calories Alone for NAFLD
(MedPage Today) -- Adding time restriction to a calorie-restricted diet didn't provide any additional benefits for nonalcoholic fatty liver disease (NAFLD), the TREATY-FLD trial found. Looking at 88 participants with obesity and NAFLD, the half... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 17, 2023 Category: Endocrinology Source Type: news

Asthenia could be an 'early' sign of liver disease - see a GP 'as soon as possible'
Feeling tired and weak could be a warning sign of the last stage of non-alcoholic fatty liver disease. (Source: Daily Express - Health)
Source: Daily Express - Health - March 9, 2023 Category: Consumer Health News Source Type: news

Long-term Exposure to Air Pollution and NAFLD and Cirrhosis Long-term Exposure to Air Pollution and NAFLD and Cirrhosis
Might long-term exposure to air pollution increase the risk of NAFLD and cirrhosis?Liver International (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 9, 2023 Category: Pathology Tags: Gastroenterology Journal Article Source Type: news